Skip to main content

Biomedical, Clinical & Life Sciences

NSF 23-538: 2023 Partnerships for Innovation (PFI) - Research Partnerships (PFI-RP) Track

No applicants // Limit: 1* // Tickets Available: 1 

 

*UA may submit one proposal under the Research Partnerships track. There is no institutional limitation on the Technology Translation track.

If you don’t have a demonstrated and substantial industry relationship as required for a PFI submission, please reach out to Brian Adair or Lindsay Ridpath, to help develop those connections so that your proposal is competitive. PFI proposals are accepted three times per year and you may be better served by strengthening your industry relationship and waiting for the next cycle.


The Partnerships for Innovation (PFI) Program within the Division of Translational Impacts (TI) offers researchers from all disciplines of science and engineering funded by NSF the opportunity to perform translational research and technology development, catalyze partnerships and accelerate the transition of discoveries from the laboratory to the marketplace for societal benefit.

The Research Partnerships (PFI-RP) track seeks to achieve the same goals as the PFI-TT track by supporting instead complex, multi-faceted technology development projects that are typically beyond the scope of a single researcher or institution and require a multi-organizational, interdisciplinary, synergistic collaboration. A PFI-RP project requires the creation of partnerships between academic researchers and third-party organizations such as industry, non-academic research organizations, federal laboratories, public or non-profit technology transfer organizations or other universities. Such partnerships are needed to conduct use-inspired research on a stand-alone larger project toward commercialization and societal impact. In the absence of such synergistic partnership, the project’s likelihood for success would be minimal.

The intended outcomes of both PFI-TT and PFI-RP tracks are: a) the commercialization of new intellectual property derived from NSF-funded research outputs; b) the creation of new or broader collaborations with industry (including increased corporate sponsored research); c) the licensing of NSF-funded research outputs to third party corporations or to start-up companies funded by a PFI team; and d) the training of future innovation and entrepreneurship leaders.


 

The please be aware of important revisions in the PFI program recently announced in solicitation NSF 23-538, as outlined below:

NSF Lineage Requirement
Innovation Corps (NSF I-CorpsTM) Teams awards no longer convey the lineage required to submit a PFI proposal.
All proposals submitted to the PFI program must meet a lineage requirement by having NSF-supported research results in any field of science and engineering: Principal Investigator (PI) or a co-PI must have had an NSF award that ended no more than seven (7) years prior to the full proposal deadline date or be a current NSF award recipient. The proposed technology development project must be derived from the research results and/or discoveries from this underlying NSF award.



Award Information
The funding amounts in both tracks of the PFI program have significantly increased. Specifically:

  • PFI-Technology Translation (PFI-TT) projects will be funded for up to $550,000 for 18-24 months per award; and

  • PFI-Research Partnerships (PFI-RP) projects will be funded for up to $1,000,000 for 36 months.
     

 

 

 

PAR-21-312: 2023 Genomic Curriculum Development for Medical Students (R25 Clinical Trial Not Allowed)

No applicants // Limit: 1 // Tickets Available: 1 

 

This NHGRI R25 program offers to support the development of curricula for Master of Science (M.S.) degree programs in genomics, genomic medicine and/or genomic informatics for medical students.

 Specifically, this FOA will support the development of curriculum designed to be freely available, at no cost to the broader community to enhance training in genomics for medical students.

Internal Deadline
External Deadline
01/25/2023

RFA-HD-23-008: 2022 NICHD Global Network for Women’s and Children’s Health Research: Research Units (UG1 Clinical Trial Optional)

No applicants // Limit: 1 // Tickets Available: 1 

 

The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) invites U.S. institutions in partnership with research centers in low and middle-income countries to submit applications as Research Units (RUs) to participate in the Global Network for Women’s and Children’s Health Research. RUs will consist of U.S.-based research centers applying in partnership with research centers in low- and lower middle-income countries as defined by the World Bank. The RU grantees will become part of a cooperative network in scientific partnership with the NIH to conduct multi-center observational studies and randomized clinical trials evaluating disease process, health and wellness outcomes, and results from interventions in resource-constrained settings to address the major causes of maternal, neonatal, infant, and early childhood morbidity and mortality.

This Funding Opportunity Announcement (FOA) invites applications for Global Network Research Units; a separate FOA invites applications for a Global Network Data Coordinating Center.

Internal Deadline
External Deadline
11/29/2022

RFA-HD-23-009: 2022 NICHD Global Network for Women’s and Children’s Health Research: Data Coordinating Center (U24 Clinical Trial Optional)

No applicants // Limit: 1 // Tickets Available: 1 

 

The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) invites U.S. institutions to submit applications to participate in the Global Network for Women’s and Children’s Health Research’s Data Coordinating Center. The Data Coordinating Center will work with Research Units of U.S.-based research centers partnering with institutions in low- and lower middle-income countries to conduct multi-center observational studies and randomized clinical trials evaluating disease process, health and wellness outcomes, and results from interventions in resource-constrained settings to address the major causes of maternal, neonatal, infant, and early childhood morbidity and mortality.

This Funding Opportunity Announcement (FOA) invites applications for a Global Network Data Coordinating Center; a separate FOA invites applications for Global Network Research Units.

Internal Deadline
External Deadline
11/29/2022

RFA-CA-22-041: 2022 The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed)

No applicants // Limit: 1 // Tickets Available: 1 

 

UArizona is eligible to submit one application per due date. The purpose of the NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00) is to encourage and retain outstanding graduate students recognized by their institutions for their high potential and strong interest in pursuing careers as independent cancer researchers. The award will facilitate the transition of talented graduate students into successful cancer research postdoctoral appointments and provide opportunities for career development activities relevant to their long-term career goals of becoming independent cancer researchers. 

Internal Deadline
External Deadline
11/18/2022
Solicitation Type

RFA-HD-23-023: 2022 Pediatric Clinical Pharmacology Research Career Development Award (K12 Clinical Trial Not Allowed)

No applicants // Limit: 1 // Tickets Available: 1 

 

This FOA encourages applications for institutional research career development (K12) programs that support mentored research and career development experiences for scholars pursuing clinical, translational, and/or basic research in pediatric therapeutics. This program constitutes a national network of mentors and scholars, in contrast to K12 programs that are based solely at a single applicant institution. The primary purpose of this FOA is to ensure that a pipeline of diverse and highly trained workforce is available in pediatric pharmacology-related clinical and biomedical fields that currently have a limited number of researchers. This FOA will support essential research career development opportunities and ensure “protected” time to pursue impactful research experiences for new faculty-level clinical pharmacologists, fostering the transition to productive highly skilled clinical pharmacologist investigators.

This initiative proposes to expand and strengthen the community of clinical pharmacologist investigators engaged in pediatric clinical pharmacology research.

Internal Deadline
External Deadline
12/06/2022

RFA-AI-22-058: 2022 National Institute of Allergy and Infectious Diseases (NIAID) Clinical Data and Safety Management Center (CDSMC) (U01 Clinical Trial Not Allowed)

No applicants // Limit: 1 // Tickets Available: 1 

 

The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for the NIAID CDSMC, which will support a broad range of critical support services, including data management and processing, safety and pharmacovigilance management and processing, and sample tracking systems for NIAID-funded clinical trials, integrated studies of underlying mechanisms, clinical studies (e.g., longitudinal studies, genetic studies, etc.), and studies to identify and validate surrogates/biomarkers of immune-mediated diseases in the areas of asthma and allergic diseases, autoimmune diseases, and transplantation.

Internal Deadline
External Deadline
11/30/2022

RFA-HD-23-027: 2022 Coordinating Center for the NICHD Population Dynamics Centers Research Infrastructure Program FY 2023 (R24 Clinical Trial Not Allowed)

No applicants // Limit: 1 // Tickets Available: 1 

 

The purpose of this funding announcement is to support a coordinating center for the NICHD Population Dynamics Centers Research Infrastructure Programs. The PDRIP is comprised of recipients that have active support from RFA-HD-18-013RFA-HD-19-014RFA-HD-20-015RFA-HD-21-010RFA-HD-22-013, and predecessor and successor announcements.

Internal Deadline
External Deadline
12/02/2022

RFA-DK-22-008: 2022 National Coordinating Center for the George M. OBrien Kidney National Resource Centers (U24 - Clinical Trial Not Allowed)

No applicants // Limit: 1 // Tickets Available: 1 

 

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) invites applications for the George M. O’Brien Kidney Consortium -- National Coordination Center (NCC) to lead a nation-wide effort to advance kidney research. The O’Brien Kidney Consortium will consist of ~8 National Resource Centers (NRCs) tasked with developing and sharing specialized kidney resources tools, technologies, services, and expertise and one NCC to lead, manage, and harmonize all aspects of the Consortium. Specifically, the NCC will: (1) provide administrative support and coordination for the entire Consortium, (2) establish and curate a “one-stop-shop” sharing portal for the entire Consortium, (3) develop and implement a multipronged communication and education plan for researchers and students interested in conducting kidney research to maximize national outreach and impact, (4) ensure that patient viewpoints, priorities, and preferences inform all aspects of the Consortium, and (5) administer and manage a national Opportunity Pool program to address gaps and promote collaboration.

Internal Deadline
External Deadline
12/01/2022